Wednesday, January 29, 2020

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.

from Moneycontrol Business News https://ift.tt/2RCYxBJ

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...